Nektar Therapeutics · NASDAQ:NKTR
BVF PARTNERS L P/IL reported a 9.80% stake in Nektar Therapeutics (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
BVF PARTNERS L P/IL reported a 9.80% stake in Nektar Therapeutics, 2,852,698 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 9.80%
- Shares
- 2,852,698
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 5.30% | 1,523,980 |
| BVF I GP LLC | 5.30% | 1,523,980 |
| BIOTECHNOLOGY VALUE FUND II LP | 3.90% | 1,114,072 |
| BVF II GP LLC | 3.90% | 1,114,072 |
| Biotechnology Value Trading Fund OS LP | 0.60% | 171,769 |
| BVF Partners OS Ltd. | 0.60% | 171,769 |
| BVF GP HOLDINGS LLC | 9.10% | 2,638,052 |
| BVF PARTNERS L P/IL | 9.80% | 2,852,698 |
| BVF INC/IL | 9.80% | 2,852,698 |
| LAMPERT MARK N | 9.80% | 2,852,698 |
Source
Related
- Nektar Therapeutics
- Bvf Partners L P
- Nektar Therapeutics shareholders
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026
- Schedule 13G · Bvf Partners L P · Jul 9, 2025
- Schedule 13G/A · Two Seas Capital LP · Sep 28, 2026
- Form 4 · Whitfield Roy A · Sep 25, 2026
- Form 4 · Greer R Scott · Sep 25, 2026
- Form 4 · Chess Robert · Sep 25, 2026
- Form 4 · Brainard Diana · Sep 25, 2026